The International Society of Cardiovascular Pharmacotherapy (ISCP) was created to support and promote ethical, evidence-based, cardiovascular pharmacotherapy worldwide. ISCP represents an ideal forum for open discussions on all issues related to cardiovascular pharmacotherapy and the society endeavours to foster collaboration among health professionals around the world. ISCP promotes education, research, and best clinical practice regarding the pharmacological treatment of cardiovascular conditions. ISCP is a member of the World Heart Federation and currently has representatives (ISCP Governors) from over 40 countries around the World. We welcome applications for membership from health professionals with an interest in cardiovascular drug treatment. For more information on our activities, e-learning programmes and to become a Member of ISCP please visit our website.
